Maven Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Maven Securities's GILD Position: Q2 2025 in Review
Maven Securities sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 4,983 shares — an estimated $530K sold.
Maven Securities first reported a position in GILD in Q4 2016 and held it in 8 quarters. The position peaked at $1.18M in Q4 2020. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- Maven Securities reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- Maven Securities sold 4,983 Gilead Sciences shares in Q2 2025, an estimated $530K.
- Maven Securities first reported a position in Gilead Sciences in Q4 2016 and held it in 8 quarters.
- Maven Securities's Gilead Sciences position peaked at $1.18M in Q4 2020.
- 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.